Covidien launches new contrast delivery system for CT
This article was originally published in Clinica
Covidien has launched its contrast delivery system with radiofrequency identification (RFID) technology in the US. The system could reduce medical errors and increase efficiency in CT imaging, the Hamilton, Bermuda-based firm said. It combines Covidien's Ultraject prefilled contrast media syringes with its Optivantage DH power injector. The RFID technology captures, stores and transmits data between the syringe and the injector, which helps technicians ensure that each patient receives the correct dose of contrast medium. The US FDA granted 510(k) clearance for the system in May.